Inventor
INAMINE EDWARD S
US18 patents
Patents
18 patentsUS5116870AMay 26, 1992
HMG-CoA reductase inhibitors
MERCK & CO INC62 citations96
US4940727AJul 10, 1990
Novel HMG-CoA reductase inhibitors
MERCK & CO INC52 citations96
USRE36520EJan 18, 2000
HMG-CoA reductase inhibitors
MERCK & CO INC31 citations92
US4981792AJan 1, 1991
Immunosuppressant compound
MERCK & CO INC34 citations92
USRE36481EJan 4, 2000
HMG-CoA reductase inhibitors
MERCK & CO INC17 citations84
US5087702AFeb 11, 1992
Microbial transformation process for producing an antihypertensive product
MERCK & CO INC21 citations82
US5290772AMar 1, 1994
Immunosuppressant agent
MERCK & CO INC7 citations73
US5070015ADec 3, 1991
Novel avermectins are produced from known microorganisms
MERCK & CO INC8 citations73
US4975372ADec 4, 1990
Microbial transformation product of L-683,590
MERCK & CO INC8 citations73
US4666937AMay 19, 1987
Avermectin bioconversion products
MERCK & CO INC13 citations73
US4997755AMar 5, 1991
HMG-CoA reductase inhibitors produced by Nocardia sp. (MA 6455)
MERCK & CO INC6 citations72
US5268370ADec 7, 1993
Microbial transformation product of L-679,934
MERCK & CO INC2 citations62
US5252612AOct 12, 1993
Microbial immunosoppressant agent
MERCK & CO INC3 citations62
US5250422AOct 5, 1993
Biotransformation process for the production of invermectin derivatives
MERCK & CO INC2 citations62
US4766112AAug 23, 1988
Anthelmintic fermentation products of a microorganism
MERCK & CO INC3 citations62
US4668696AMay 26, 1987
Novel averonectin fermentation product of a microorganism with anthelmintic activity
MERCK & CO INC3 citations62
US5202258AApr 13, 1993
Immunosuppressant-producing culture
MERCK & CO INC2 citations61
US4696925ASep 29, 1987
Cholecystokinin antagonist compounds
MERCK & CO INC2 citations61